Association of virulent genes hly, sfa, cnf-1 and pap with antibiotic sensitivity in Escherichia coli strains isolated from children with community-acquired UTI

Iranian Red Crescent Medical Journal

Volumn 12, Issue 1, 2010, Pages 33-37

  Farshad, Shohreh ^a   Emamghoraishi, F ^b   Japoni, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cnf 1; Drug resistance; E coli; hly; pap; sfa; UTI

Indexed keywords

AMIKACIN; AMPICILLIN; CEFIXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; PROTEIN CNF 1; PROTEIN HLY; PROTEIN PAP; PROTEIN SFA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; GENE EXPRESSION; GENOTYPE; HUMAN; INFANT; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; URINARY TRACT INFECTION; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI;

EID: 73849138955     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, Moreno A, Mensa J. Are Quinolone-Resistant Uropathogenic Escherichia coli Less Virulent? J Infect Dis 2002;186: 1039-42. [12232848] [doi:10.1086/ 342955]
2. Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997; 11:513-29. [9378921] [doi:10.10 16/S0891-5520(05)70371-8]
3. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4:80-128. [1672263]
4. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Esherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 1995;12:85-90. [8589667] [doi:10.1111/j.1574-695X.1995.tb00179.x]
5. Johnson JR, Stapleton AE, Russo TA, Scheutz F, Brown JJ, Maslow JN. Charecteristcs and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Esherichia coli O4: H5 containing the class I and class III alleles of pap G. Infect Immun 1997;65:2153-9. [9169745]
6. Donnenberg MS, Welch RA. Virulence determinants of uropathogenic Escherichia coli. in: Mobley HLT, Warren JW. Eds. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management. Washington, DC: ASM Press. 1996; pp. 135-174.
7. Orskov I, Orskov F. Esherichia coli in extra-intestinal infections. J Hyg (Lond) 1985;95:551-75. [2419401]
8. Hacker J, Blum-Oehler G, Mühldorfer I, Tschäpe H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997;23:1089-97. [9106201] [doi:10.1046/j.1365-2958. 1997.3101672.x]
9. Velasco M, Horcajada JP, Mensa J, Moreno-Martinez A, Vila J, Martinez JA, Ruiz J, Barranco M, Roig G, Soriano E. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis 2001;33:1682-6. [11595990] [doi:10. 1086/323810]
10. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOSdependent or -independent pathways, respectively. Antimicrob Agents Chemother 2006;50:649-53. [16436722] [doi:10.1128/AAC.50.2. 649-653.2006]
11. Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, Vila J, Johnson JR. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005;43: 2962-4. [15956432] [doi:10.1128/ JCM.43.6.2962-2964.2005]
12. Farmer JJ. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Phaler MA, Tenover FC, Yolken RH eds: Manual of clinical microbiology. 7nd ed. Washington, ASM Press. 1999; p. 438.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement Villanova, PA: National Committee for Clinical Laboratory Standards (NCCLS) 2000; Approved standard M2 A7.
14. Arisoy M, Aysev D, Ekim M, Özel D, Köse SK, Özsoy ED, Akar A. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction. Inter J Clin Pract 2006;60:170-3. [16451289] [doi:10.1111/j.1742-124 1.2005.00668.x]
15. Garcia MI, Le Bouguénec C. Role of adhesion in pathogenicity of human uropathogenic and diarrhoeogenic Escherichia coli. Bull Inst Pasteur 1996;94:201-36. [doi:10.1016/S0020 -2452(97)86017-4]
16. Usein CR, Damian M, Tatu-Chitoiu D, Capusa C, Fagaras R, Tudorache D, Nica M, Le Bouguénec C. Prevalence of virulence genes in Escherichia coli strains isolated from Romanian adult urinary tract infection cases. J Cell Mol Med 2001; 5:303-10. [12067489] [doi:10.1111/j. 1582-4934.2001.tb00164.x]
17. Wullt B. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int J Antimicrob Agents 2003;21:605-21. [13678032] [doi:10. 1016/S0924-8579(02)00328-X]
18. Martínez-Martínez L, Fernández F, Perea EJ. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother 1999;43:277-9. [11252 335] [doi:10.1093/jac/43.2.277]
19. Lepelletier D, Caroff N, Reynaud A, Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis 1999;29:548-52. [10530446] [doi:10.1086/598632]
20. Johnson JR, Moseley SL, Roberts PL, Stamm WE. Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics. Infect Immun 1988; 56:405-12. [2892793]
21. Blum G, Ott M, Lischewski A, Ritter A, Imrich H, Tschäpe H, Haker J. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wildtype pathogen. Infect Immun 1994;62:606-14. [7507897]
22. Ott M. Dynamics of the bacterial genome: deletions and integrations as mechanisms of bacterial virulence determination. Zentbl Bakteriol 1993;278:457-68. [8353320]
23. Middendorf B, Hochhut B, Leipold K, Dobrindt U, Blum-Oehler G, Hacker J. Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J Bacteriol 2004;186:3086-96. [15126470] [doi:10.1128/JB.186.10. 3086-3096.2004]
24. Phillips I, Culebras E, Moreno F, Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987;20:631-8. [3323160] [doi:10.1093/jac/20.5.631]
25. Bagel S, Hüllen V, Wiedemann B, Heisig P. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother 1999;43:868-75. [10103193]